the market is forward looking, so if there is a BLA 2H25, I believe it will be seen to have a good chance of approval given the FDa will have allowed it for AA. That means less of a risk factor added to the expectation of all the rest of it coming in 2026. I think it will cause a significant uptick and possibly even more pronounced with the current absurdly low price and shorting. The approval and income from actual marketing of the drug will be factored into the stock price way before it actually happens.
IMM Price at posting:
24.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)